Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Kanglaite injection plus Kanglaite capsules in malignant tumors
ChiCTR1800015312Phase 4Recruiting
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Apr 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of kanglaite in liver cancer, bronchial carcinoma and pancreatic cancer (PC), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Primary endpoints: Nutritional status score, Safety and 1 more. Started Apr 2018; status: recruiting.
02
Drugs
kanglaite
03
Conditions
liver cancerbronchial carcinomapancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR1800015312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015312.